Bonus Biogroup (BONS) - Total Liabilities

Latest as of December 2025: ILA21.11 Million ILA ≈ $56.58K USD

Based on the latest financial reports, Bonus Biogroup (BONS) has total liabilities worth ILA21.11 Million ILA (≈ $56.58K USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore BONS net asset momentum to track the company's year-over-year net asset growth rate.

Bonus Biogroup - Total Liabilities Trend (2008–2025)

This chart illustrates how Bonus Biogroup's total liabilities have evolved over time, based on quarterly financial data. See how much free cash does Bonus Biogroup generate to measure how efficiently the company converts operating cash flow to free cash.

Bonus Biogroup Competitors by Total Liabilities

The table below lists competitors of Bonus Biogroup ranked by their total liabilities.

Company	Country	Total Liabilities
IBI Lion SOCIMI S.A. MC:YIBI	Spain	€54.88 Million
Applied BioCode TW:6598	Taiwan	NT$343.23 Million
Maywufa Co Ltd TW:1731	Taiwan	NT$1.02 Billion
Cartica Acquisition Corp NASDAQ:CITE	USA	$8.99 Million
Terracom Ltd AU:TER	Australia	AU$161.47 Million
Torque Metals Ltd AU:TOR	Australia	AU$3.83 Million
Haivision Systems Inc TO:HAI	Canada	CA$47.46 Million
G Collado S.A.B. de C.V MX:COLLADO	Mexico	MX$3.36 Billion

Liability Composition Analysis (2008–2025)

This chart breaks down Bonus Biogroup's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see BONS market cap overview.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.13	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-3.73	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	1.37	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Bonus Biogroup's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Bonus Biogroup (2008–2025)

The table below shows the annual total liabilities of Bonus Biogroup from 2008 to 2025.

Year	Total Liabilities	Change
2025-12-31	ILA21.11 Million ≈ $56.58K	+28.31%
2024-12-31	ILA16.45 Million ≈ $44.10K	+5.55%
2023-12-31	ILA15.58 Million ≈ $41.78K	-14.47%
2022-12-31	ILA18.22 Million ≈ $48.85K	-8.40%
2021-12-31	ILA19.89 Million ≈ $53.33K	-4.15%
2020-12-31	ILA20.75 Million ≈ $55.64K	+0.20%
2019-12-31	ILA20.71 Million ≈ $55.53K	+55.31%
2018-12-31	ILA13.34 Million ≈ $35.75K	+11.49%
2017-12-31	ILA11.96 Million ≈ $32.07K	+16.59%
2016-12-31	ILA10.26 Million ≈ $27.50K	+43.58%
2015-12-31	ILA7.14 Million ≈ $19.16K	+82.32%
2014-12-31	ILA3.92 Million ≈ $10.51K	+128.91%
2013-12-31	ILA1.71 Million ≈ $4.59K	+23.97%
2012-12-31	ILA1.38 Million ≈ $3.70K	+54.99%
2011-12-31	ILA891.00K ≈ $2.39K	-97.99%
2010-12-31	ILA44.26 Million ≈ $118.67K	-24.68%
2009-12-31	ILA58.77 Million ≈ $157.56K	+50.91%
2008-12-31	ILA38.94 Million ≈ $104.40K	--

About Bonus Biogroup

TA:BONS Israel Biotechnology

Market Cap

$86.42 Million

ILA32.23 Billion ILA

Market Cap Rank

#19678 Global

#256 in Israel

Share Price

ILA27.60

Change (1 day)

-1.08%

52-Week Range

ILA21.10 - ILA58.50

All Time High

ILA171.00